A local sleeper medical technology company has ambitious plans to move into commercial production, and won’t rule out an initial public offering.
Read more about Nexus6 – Sleeper medical technology company stirs.
Read more about SeaDragon Investor Presentation June 2014
Australia, 11 June 2014. ASX announcement here.
Read more about Avita Medical – Positive ReCell repigmentation trial results
Australasia’s largest refiner and blender of fish oils SeaDragon (NZX:SEA) today reports a year of good progress putting in place the foundations for its future growth.
Read more about SeaDragon poised for significant growth
Nexus6 Ltd, has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for its new SmartTouch inhaler monitoring device.
Read more about Nexus6 Receives FDA Clearance for Latest Smartinhaler